Ascension Asset Management LLC Pfizer Inc Transaction History

Ascension Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $8,350 - $10,900	200 Added 3.23%	6,393 $327,000
Q2 2021 Jul 29, 2021	SELL	$35.91 - $40.68 $10,772 - $12,204	-300 Reduced 4.62%	6,193 $243,000
Q1 2021 May 04, 2021	BUY	$33.49 - $37.77 $217,450 - $245,240	6,493 New	6,493 $235,000
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $239,277 - $304,261	-7,149 Closed	0 $0
Q3 2020 Oct 19, 2020	BUY	$31.75 - $37.25 $8,096 - $9,498	255 Added 3.7%	7,149 $262,000
Q2 2019 Jul 23, 2019	SELL	$36.98 - $41.52 $36,980 - $41,520	-1,000 Reduced 12.67%	6,894 $299,000
Q3 2018 Oct 30, 2018	SELL	$34.47 - $41.81 $59,977 - $72,749	-1,740 Reduced 18.06%	7,894 $348,000
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $65,960 - $70,320	-2,000 Reduced 17.19%	9,634 $350,000
Q1 2018 Apr 17, 2018	SELL	$31.91 - $37.02 $31,910 - $37,020	-1,000 Reduced 7.92%	11,634 $413,000
Q4 2017 Jan 24, 2018	BUY	$33.26 - $35.29 $420,206 - $445,853	12,634	12,634 $458,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ascension Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ascension Asset Management LLC with notifications on news.